Patient organization donor share in life sciences deals

STO-REC-STAT60C6JQT3 Research
75%

Global · as of 5 Oct 2023

Patient organization donor share in life sciences deals worldwide stood at 75% as of 5 October 2023 (IQVIA).

Original source
Publisher
IQVIA
Authority tier
T3 Research
Locator
Three quarters of all deals find patient organizations in the role of donor, providing grants or use of intellectual property to life sciences companies, but collaborative research is decreasing.
Retrieved
16 Sep 2026
Status
Verified

What the source says

Patient organizations act as donors — providing grants or use of intellectual property to life sciences companies or academic parties jointly — in 75% of all deals, with two-thirds of their support going to small and emerging companies, and most of the rest to mid-sized companies (see blue in chart above).

IQVIA Institute, Supporting patients through research collaboration · Three quarters of all deals find patient organizations in the role of donor, providing grants or use of intellectual property to life sciences companies, but collaborative research is decreasing.
Verbatim extraction verified: The figure 75% is directly attested in the quoted passage (Three quarters of all deals find patient organizations in the role of donor, providing grants or use of intellectual property to life sciences companies, but collaborative research is decreasing.).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
IQVIA Institute. (2023). Supporting patients through research collaboration. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Via StatOrigin, https://statorigin.org/stat/stat_60C6JQGA219JGQCB4ZSX8WZEW4
MLA
IQVIA Institute. "Supporting patients through research collaboration." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed 16 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_60C6JQGA219JGQCB4ZSX8WZEW4.
Chicago
IQVIA Institute. "Supporting patients through research collaboration." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_60C6JQGA219JGQCB4ZSX8WZEW4.
BibTeX
@misc{iqvia2023patient8wzew4, author = {{IQVIA Institute}}, title = {Supporting patients through research collaboration}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_60C6JQGA219JGQCB4ZSX8WZEW4}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT60C6JQ T3 Research

Primary Source

Publisher
IQVIA Institute · homepage ↗
Authority tier
Tier 3 · Industry & Research
Report
Supporting patients through research collaboration
Type
Press release
Published
Locator
Three quarters of all deals find patient organizations in the role of donor, providing grants or use of intellectual property to life sciences companies, but collaborative research is decreasing.
Retrieved
16 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_60C6JQGA219JGQCB4ZSX8WZEW4